Safety of long-acting beta2-agonists in the management of asthma: a Primary Care Respiratory Alliance of Canada perspective.
D'Urzo
Anthony D
AD
Department of Family and Community Medicine, University of Toronto, Ontario, Canada. tonydurzo@sympatico.ca
Jugovic
Pieter
P
Bouchard
Jacques
J
Jhirad
Reuven
R
Tamari
Itamar
I
D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000517:prevention & control; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D006801:Humans
D058666:Adrenergic beta-2 Receptor Agonists; D003692:Delayed-Action Preparations